Istituto Nazionale per lo Studio e la Cura dei Tumori
Also known as: Fondazione IRCCS "Istituto Nazionale Tumori" - Milan (Italy) | IRST IRCCS | IRST IRCCS, Meldola | IRST IRCCS, Meldola-Cesena | IRST IRCCS, Meldola (FC) | IRST - ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST Italy | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) | Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS , Meldola Italy | Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) Meldola | Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Via Maroncelli 40, 47014 Meldola, ITALY | UO Immunoterapia e Laboratorio TCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) S.r.l IRCCS | UO Immunoterapia e Laboratorio TCS, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) S.r.l IRCCS
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Sep 1, 2024
Timeline
2000s
- Jan 1, 2007
Istituto Nazionale per lo Studio e la Cura dei Tumori— Founded
Drugs by trial phase (63 distinct, 56 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (37 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenoma, Islet Cell
- Breast Neoplasms
- Carcinoma
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Colorectal Neoplasms
- Coronavirus Infections
- Disease Progression
- Esophageal Neoplasms
- Gastrointestinal Stromal Tumors
- Glioblastoma
- Head and Neck Neoplasms
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, Mantle-Cell
- Melanoma
- Mesothelioma
- Nausea
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Neuroendocrine Tumors
- Pancreatic Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Neoplasms
- Rectal Neoplasms
- Sarcoma
- Skin Neoplasms
- Small Cell Lung Carcinoma
- Vomiting
Recent trials (50)
- NCT06522919Lead sponsorPhase 2Sep 1, 2024
- NCT06390241Lead sponsorPhase 1Jun 19, 2024
- NCT06045260Lead sponsorPhase 2Oct 31, 2023
- NCT05893381Lead sponsorPhase 2Jun 27, 2023
- NCT05861336Lead sponsorPhase 2May 31, 2023
- NCT05867615Lead sponsorPhase 2May 25, 2023
- NCT05623319Lead sponsorPhase 2Dec 31, 2022
- NCT04775602Overall official - principal investigatorPhase 2May 31, 2021
- NCT04775602Lead sponsorPhase 2May 31, 2021
- NCT04523688Lead sponsorPhase 2Dec 31, 2020
- NCT04523688Study chairPhase 2Dec 31, 2020
- NCT04363827Study chairPhase 2May 31, 2020
- NCT04363827Lead sponsorPhase 2May 31, 2020
- NCT04166006Lead sponsorPhase 2Dec 31, 2019
- NCT04166006Study chairPhase 2Dec 31, 2019
Details
- Founded
- Forli, IT Jan 1, 2007
- Last known activity
- Sep 1, 2024
Notes
--- Pre-folding founded info: None None None None None ---